Moreover, we pretreated SMYD2 overexpressed HCC cells with 10058-F4, a specific c-Myc inhibitor, and c-Myc siRNA to effectively suppressed their c-Myc expression. This evidence concerns the gene MYC and hepatocellular carcinoma.